• Cancer Patient’s Genetic Ancestry Helps Predict Survival

    Diagnostics World | Research presented at the annual conference of the European Society of Human Genetics shows that a cancer patient’s genetic ancestry can have a significant effect both on how their disease progresses and their survival. In the largest study of its kind, researchers examined nearly 1,900 specific genetic changes in tumors in order to measure whether certain mutations were more common in patients with different historic geographic origins.

    Jun 25, 2026

  • Comparing Women’s Risk Scores Longitudinally Could Significantly Change Breast Cancer Screening

    Diagnostics World | Researchers from Japan have developed a machine learning framework called DiSPAH (Disease-progression Speed and Pathway Analysis based on a Hidden Markov model) to estimate both the pathway and speed of disease progression in individual patients.

    Jun 24, 2026

  • INTACT: Detecting Gene Transcription in Living Animals

    Diagnostics World | In a first, researchers at Rice University have established a method for measuring the levels of specific mRNA transcripts in the brain of a live animal. Being able to keep the animal alive is a critical detail, because current methods for analyzing transcript levels are generally only useful post-mortem.

    Jun 23, 2026

  • Algorithm Predicts ALS Progression Pathway, Speed

    Diagnostics World | Researchers from Japan have developed a machine learning framework called DiSPAH (Disease-progression Speed and Pathway Analysis based on a Hidden Markov model) to estimate both the pathway and speed of disease progression in individual patients.

    Jun 18, 2026

  • Biological Age Blood Test Predicts Diseases Before Onset

    Diagnostics World | Researchers at Stanford University have developed a blood test that reveals the functional age of your organs, predicting the odds of specific organ diseases within ten years, and opening new diagnostic avenues. In a study published in Nature Medicine, researchers showed that not only our organs, but individual cell types within those organs, can be classified by biological rather than chronological age, revealing even more precise data enabling potentially superior diagnostic approaches.

    Jun 16, 2026

  • At Any Age, the Business of Assessing Cancer Risk is Complicated

    Diagnostics World | A single laboratory-developed blood test, years in the making at The University of Texas MD Anderson Cancer Center, could soon be a clinical reality for determining the risk of nine different cancers. In collaboration with UT MD Anderson, Quest Diagnostics is developing and validating the test based on a handful of circulating protein biomarkers associated with high risk for one or more of the cancers, including colorectal, lung, breast, pancreatic, ovarian, liver, prostate, esophageal, and stomach.

    Jun 11, 2026